|
GIT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.22770000005246E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.015600E-04 |
| Normal-vs-Stage2 |
5.909800E-02 |
| Normal-vs-Stage3 |
3.45300000037518E-07 |
| Normal-vs-Stage4 |
1.63589999990776E-07 |
| Stage1-vs-Stage2 |
2.378800E-01 |
| Stage1-vs-Stage3 |
2.367600E-02 |
| Stage1-vs-Stage4 |
3.421300E-03 |
| Stage2-vs-Stage3 |
8.578700E-03 |
| Stage2-vs-Stage4 |
2.321300E-03 |
| Stage3-vs-Stage4 |
4.119200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.37190000004672E-06 |
| Normal-vs-AfricanAmerican |
1.004150E-02 |
| Normal-vs-Asian |
6.604000E-02 |
| Caucasian-vs-AfricanAmerican |
5.844600E-01 |
| Caucasian-vs-Asian |
3.813800E-02 |
| AfricanAmerican-vs-Asian |
3.699200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.375000E-04 |
| Normal-vs-Female |
1.7425999999654E-06 |
| Male-vs-Female |
3.891400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.005700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.87868999999008E-05 |
| Normal-vs-Age(61-80Yrs) |
5.90129999999967E-05 |
| Normal-vs-Age(81-100Yrs) |
7.436100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.414400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.064400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.926000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.723800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.739200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.057400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.478800E-03 |
| Classical-VS-Follicular |
2.311700E-02 |
| Classical-VS-Other |
2.986600E-01 |
| Classical-VS-Normal |
1.60903999999462E-05 |
| Tall-VS-Follicular |
8.07810000000853E-05 |
| Tall-VS-Other |
6.747800E-01 |
| Tall-VS-Normal |
2.76269999988088E-07 |
| Follicular-VS-Other |
1.417580E-02 |
| Follicular-VS-Normal |
4.684300E-02 |
| Other-VS-Normal |
7.956000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.779860E-04 |
| Normal-vs-N1 |
1.08770000006864E-07 |
| N0-vs-N1 |
8.679500E-03 |
|
|
